JCI paper showing IgG fibromyalgia pts given to mice leads to passive transfer of FM symptoms leads to sensory hypersensitivity; increased sensitivity to noxious mechanical & cold stimulation, & nociceptive fibers in skin-nerve preparations.WHAT? https://t.co/af24a9BzzW

• https://bit.ly/3sXkmgx

New podcast available--Dr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19. https://t.co/rugwkPb8KQ https://t.co/dCCzlemjfu

• https://bit.ly/3DsUded

We've got another resource available on Cytokine Storm Management. Log in and download today. https://t.co/dTAzMVa6SB https://t.co/BvsZFxGrQl

• https://bit.ly/38mSb0P

The current NEJM reports that the use of the Pfizer mRNA vaccine (BNT162b2) demonstrated a very low risk for certain serious adverse events, including the risk of myocarditis (1 to 5 events per 100,000 persons). https://t.co/CT4dQK9XlH https://t.co/enddiHtX1G

• https://bit.ly/3zisuul

1458 RA patients (74% seropositive) followed longitudinally for ROM & surgical outcomes. Seropositive and seronegative patients had loss of ROM over time (7–13%/Yr), and surgical needs. T2T approaches should be followed irrespective of RF status https://t.co/ohmDTLfP9S

• https://bit.ly/3mOZd75

85% relapse median 22 wks , 20% ISR, quickly regain MDA, why would you? https://t.co/VtQ3ClumBl

• https://onlinelibrary.wiley.com/doi/full/10.1002/art.41716?campaign=woletoc

Can an anti-inflammatory diet impact axial spondyloarthritis (axSpA)? A 6-month dietary intervention shows that adherence to a Mediterranean diet lowers disease activity in axSpA; but dietary adherence is often incomplete. https://t.co/AqtYO60XbH https://t.co/uYil2YvOR1

• https://bit.ly/2XWVvOh

A current report in Arthritis & Rheumatology examined the Nurses Health Study II data set and shows that parental smoking, and passive exposure to children, can later lead to an increased risk of adult-onset incident seropositive RA. https://t.co/szl5L7DGJG https://t.co/vAXBNPxsWU

• https://bit.ly/3zi2NKy

Arthritis clinic referrals divided into 2 cohorts: (A) 163 w/ MSK US before visit; (B) 109 without initial MSK US. MSK-US at 1st visit reduced time to Dx from mean 31 to 12 days (p< 0.01), # of clinic visits, & increased odds of inflamm Dx (47% vs 27%) https://t.co/FaXLBlRlxy

• https://bit.ly/2ULWI9Z

Rheumatic Events With Checkpoint Inhibitors: Tumor Type Matters https://t.co/vT6185ycoG https://t.co/G14eLN2JkT

• https://bit.ly/2Wo0eru

Si @DGlaucomflecken es el mejor se dice y ya está https://t.co/QzPyIe5gAA

New podcast available for download! COVID Marching Amidst the Madness https://t.co/xYzkw3zGRt https://t.co/gv45nVk9v5

• https://bit.ly/3zilVId

In case you missed it: Biologic Therapy of Psoriasis May Prevent Psoriatic Arthritis Another retrospective cohort study has shown that biologic treatment of psoriasis may reduce the subsequent incidence of psoriatic arthritis (PsA). https://t.co/2YbLBsFedv https://t.co/OYMJ6Y54UF

• https://bit.ly/3kqtVk6

ICYMI: European Commission approves upadacitinib (Rinvoq)-first JAK Inhibitor for use in adults & adolescents with Moderate to Severe Atopic Dermatitis. UPA is approved for atopic dermatitis in other nations, Russia, Saudi Arabia; pending review in US https://t.co/hiPkJoJCex

• https://bit.ly/2WrY9vd

ICYMI: European Commission has approved tofacitinib (Xeljanz) to treat active polyarticular juvenile idiopathic arthritis & juvenile psoriatic arthritis (PsA) > 2yrs old, not responding to DMARDs (as tablet & new oral solution (weight-based dosing) https://t.co/FyqZI0qsYa

• https://bit.ly/2WfWp84